News|Articles|February 10, 2023
SCOPE 2023: Biopharma Insights
Author(s)Andy Studna, Senior Editor
Murray L. Aitken, SVP of IQVIA offers insights that small biopharma organizations can take away from larger companies at the SCOPE 2023 conference in Orlando, FL.
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Murray L. Aitken, SVP of IQVIA discusses what small biopharma organizations can take away from larger companies.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
5